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SUMMARY
Clostridium difficile, is an anaerobic pathogen that forms spores which promote survival in the 
environment and transmission to new hosts. The regulatory pathways by which C. difficile initiates 
spore formation are poorly understood. We identified two factors with limited similarity to the Rap 
sporulation proteins of other spore-forming bacteria. In this study, we show that disruption of the 
gene CD3668 reduces sporulation and increases toxin production and motility. This mutant was 
more virulent and exhibited increased toxin gene expression in the hamster model of infection. 
Based on these phenotypes, we have renamed this locus rstA, for regulator of sporulation and 
toxins. Our data demonstrate that RstA is a bifunctional protein that upregulates sporulation 
through an unidentified pathway and represses motility and toxin production by influencing sigD 
transcription. Conserved RstA orthologs are present in other pathogenic and industrial Clostridium 
species and may represent a key regulatory protein controlling clostridial sporulation.
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INTRODUCTION
For the obligate anaerobe Clostridium difficile, the formation of a dormant spore is a critical 
transition within its life cycle. C. difficile spore formation permits long-term persistence 
outside the host, provides recalcitrance from anti-infectives and facilitates efficient 
transmission from host to host (Deakin et al., 2012). While C. difficile exhibits the same 
morphological features throughout each sporulation stage as the model organism, B. subtilis, 
many of the regulatory proteins that control the early stages of sporulation are not conserved 
or readily apparent within the C. difficile genome (Paredes et al., 2005, Pereira et al., 2013, 
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Saujet et al., 2013, Fimlaid et al., 2013, Edwards & McBride, 2014). Therefore, the 
regulatory mechanisms that govern the initiation of spore formation in C. difficile are mostly 
unknown, with only a few regulatory proteins identified and studied thus far (Underwood et 
al., 2009, Saujet et al., 2011, Deakin et al., 2012, Edwards et al., 2014, McBride, 2014). 
These include the master regulator of sporulation, Spo0A, which is a highly conserved 
transcriptional regulator, and the stationary phase sigma factor, SigH, both of which are 
found in all studied endospore-formers. Spo0A and SigH regulate the expression of early 
sporulation-specific genes and are required for the initiation of sporulation (Deakin et al., 
2012, Rosenbusch et al., 2012, Saujet et al., 2011).
Recently, our work revealed that C. difficile initiates sporulation in response to nutrient 
availability and uptake (Edwards et al., 2014). The loss of two oligopeptide permeases, Opp 
and App, results in increased sporulation, likely due to the inability of the mutant to import 
small peptides as a nutrient source (Edwards et al., 2014). In other Gram-positive species, 
Opp and App also import small quorum sensing peptides, which control a vast array of 
physiological processes, including sporulation, competence, conjugation, toxin expression 
and production of other virulence factors (Rudner et al., 1991, Perego et al., 1991, Koide & 
Hoch, 1994, Leonard et al., 1996, Solomon et al., 1996, Gominet et al., 2001, Chang et al., 
2011). In B. subtilis, the Phr quorum sensing peptides positively regulate sporulation 
initiation. The Phr peptides are synthesized within the cell, exported and processed, 
accumulate in high cell density conditions, and are then imported back into the cell by Opp 
and App (Perego & Hoch, 1996, Perego, 1997, Jiang et al., 2000). Once inside the cell, the 
Phr peptides promote sporulation by binding to and inhibiting the activity of the Rap 
phosphatases (Perego, 1997, Lazazzera et al., 1997). The Rap phosphatases indirectly 
prevent phosphorylation of Spo0A and thus, inhibit spore formation (Perego et al., 1994). 
This regulatory pathway is one of several in B. subtilis that modulate the level of 
phosphorylated (active) Spo0A, thereby ensuring that sporulation initiation is appropriately 
controlled.
The B. subtilis Rap phosphatases belong to the RNPP (Rap/NprR/PlcR/PrgX) family of 
cytoplasmic proteins (Declerck et al., 2007), or the RRNPP family, to include the 
Streptococcus Rgg proteins (Mashburn-Warren et al., 2010, Parashar et al., 2015). The C. 
difficile genome encodes two potential RNPP proteins (CD2123 and CD3668) (Edwards & 
McBride, 2014, Edwards et al., 2014). This study was undertaken to determine whether 
either RNPP-like protein has a role in C. difficile spore formation. Herein, we describe one 
RNPP ortholog, CD3668, which regulates multiple physiological traits in vitro, including 
sporulation, motility and toxin production. Our results also indicate that CD3668 is a 
bifunctional protein that influences spore formation and toxin expression in vivo and is 
important for virulence in an animal model of CDI. This study provides the first evidence 
that an RNPP protein controls spore formation and other virulence traits in Clostridium and 
closely related organisms.
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RESULTS
Identification and disruption of two putative RNPP orthologs in C. difficile
CD2123 and CD3668 possess multiple, conserved tetratricopeptide repeat (TPR) domains, 
which are a core feature of Gram-positive proteins belonging to the RNPP (Rgg/Rap/NprR/
PlcR/PrgX; or RRNPP) family (Declerck et al., 2007, Parashar et al., 2015; Fig. 1). The Rap 
proteins directly bind and dephosphorylate their molecular target: Spo0F, a member of the 
phosphorylation-dependent pathway that activates Spo0A, and ComA, the regulator of 
competence in Bacillus species (Perego et al., 1994, Core & Perego, 2003, Bongiorni et al., 
2005). The other RNPP members include the Bacillus NprR and PlcR, the Enterococcus 
PrgX and Streptococcus Rgg proteins, which are DNA-binding transcription factors. NprR 
from Bacillus thurigiensis contains a bifunctional N-terminal region comprised of a helix-
turn-helix (HTH) DNA-binding domain followed by a Spo0F-binding domain (Cabrera et 
al., 2014). NprR is the only published dual-function protein in the RNPP family.
Neither CD2123 nor CD3668 encode an identifiable phosphatase domain, a hallmark feature 
of the Rap phosphatase proteins. Besides the TPR domains identified within CD2123, this 
protein does not encode any other apparent protein motifs. The CD3668 sequence contains a 
conserved HTH DNA-binding motif in the N-terminal region, followed by five TPR repeat 
regions (Fig. 1). Protein structure modeling analysis using Phyre2 (Kelley et al., 2015) 
revealed that the predicted structure of CD3668 models to several members of the RNPP 
family, including PlcR of Bacillus thuringiensis, NprR of the Bacillus cereus group and 
RapH, RapI and RapJ from B. subtilis. There is a high degree of similarity in CD3668 to 
both the N-terminal HTH DNA-binding motif and the peptide-interacting TPR domains of 
PlcR and NprR (Grenha et al., 2013). Although there is structural similarity between 
CD3668 and the B. subtilis RapH, RapI and RapJ proteins, only 4 of 18 identified amino 
acids required for Rap-dependent Spo0F-binding and dephosphorylation are conserved in 
CD3668 (Parashar et al., 2011, Parashar et al., 2013; not shown). Altogether, these structural 
analyses provide evidence that CD3668 is related to the transcriptional regulators in the 
RNPP family. While the predicted Phyre2-generated protein structure of CD2123 is 
predominantly alpha-helical, there was little similarity to any prokaryotic proteins, 
suggesting that CD2123 may function differently than other RNPP proteins.
Disruption of CD3668 decreases sporulation frequency in C. difficile
In Bacillus species, the Rap and NprR proteins inhibit sporulation by directly binding and 
dephosphorylating Spo0F, an intermediate phosphotransfer protein in the sporulation 
phosphorelay (Perego et al., 1994, Cabrera et al., 2014). The sporulation phosphorelay 
modulates the phosphorylation state of the master sporulation regulator, Spo0A, in response 
to a variety of intracellular and environmental signals. Many of the B. subtilis Rap proteins 
inhibit sporulation; hence, overexpression of these proteins lowers the sporulation frequency 
while null mutations in these loci often result in increased sporulation frequency (Perego et 
al., 1994, Mueller & Sonenshein, 1992). There is no sporulation phosphorelay encoded in 
the C. difficile genome (Paredes et al., 2005, Sebaihia et al., 2006). In C. difficile, Spo0A 
appears to be activated by phosphorylation directly by sporulation kinases (Underwood et 
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al., 2009), and it is expected that Spo0A can be directly inactivated, as well (Paredes et al., 
2005, Edwards & McBride, 2014, Underwood et al., 2009).
To determine if CD2123 or CD3668 is important for C. difficile spore formation, we created 
independent insertional mutations in these genes. Antibiotic resistance markers were 
introduced in CD2123 at nucleotide 553 and in CD3668 at nucleotide 306, using a 
TargeTron-based group II intron. The presence of the retargeted intron in the correct gene 
was confirmed by Southern blot analysis (Fig. S1A), and qRT-PCR analysis confirmed a 
significant reduction of CD2123 and CD3668 transcript levels in the respective mutants 
(Fig. S1B and S1C). Transcription of CD3667, CD3666 and CD3665, the genes immediately 
downstream of CD3668, were slightly decreased in the CD3668 mutant (Fig. S1C), while 
CD3664 expression was unchanged. PCR analysis of cDNA from 630Δerm confirmed that 
CD3668-CD3667-CD3666-CD3665-CD3664 constitute a transcriptional unit (Fig. S1D, E); 
however, our transcriptional data suggest that the full 3.83 kb region may be a minor product 
since transcript levels of the downstream genes are not as greatly affected by the insertional 
mutation in CD3668. CD3667 is annotated as a selenium metabolism protein, CD3666 and 
CD3665 as hypothetical proteins and CD3664 as an aminotransferase, and are all 
uncharacterized, to our knowledge.
The CD2123 and CD3668 mutants (MC379 and MC391, respectively) were tested for 
sporulation frequency after 24 h of growth (H24) on 70:30 sporulation agar (Putnam et al., 
2013). Using phase-contrast microscopy to differentiate vegetative bacilli from phase bright 
spores, we observed a mean sporulation frequency of 28.1% in the parent strain, 630Δerm 
(Fig. 2A), consistent with previously published results (Putnam et al., 2013). The CD2123 
mutant demonstrated a similar sporulation frequency to the parent strain (Fig. 2A). In 
contrast, the CD3668 mutant produced ~20-fold less spores than the parent strain (1.4% in 
the CD3668 versus 28.1% in 630Δerm; Fig. 2A), suggesting that CD3668 is important for 
sporulation in C. difficile. When enumerating ethanol resistant spores from strains grown on 
70:30 sporulation agar at H24, a ~25-fold decrease in sporulation frequency in the CD3668 
mutant compared to 630Δerm was observed (Table 1), which corroborates the 
oligosporogenous phenotype ascertained with phase contrast microscopy. When a plasmid 
copy of CD3668, driven by the nisin-inducible cprA promoter (McBride & Sonenshein, 
2011b, McKee et al., 2013), was introduced into the CD3668 mutant (MC480), the 
sporulation phenotype was partially restored in a manner relative to the amount of inducer 
added to the medium (Fig. 2B). The sporulation frequency of the CD3668 mutant containing 
the pPcprA-CD3668 construct (MC480) was 1.9% in the absence of nisin, and increased to 
13.3% in 0.5 μg ml−1 nisin and 17.3% in 1 μg ml−1 nisin (Fig. 2B), confirming that CD3668 
positively influences sporulation in C. difficile. The inability to fully complement the 
sporulation phenotype may be due to exogenous CD3668 expression driven from an 
inducible promoter on a plasmid, rather than from the native promoter on the chromosome, 
which may not reflect native expression patterns. Overexpression of CD3668 in the parent 
background (MC478) did not increase sporulation frequency (Fig. 2B).
Sporulation is a complex process in bacteria and is defined by multiple morphological stages 
(Errington, 2003, Pereira et al., 2013, Paredes-Sabja et al., 2014). Specific genetic and 
regulatory events are required to complete each morphological stage throughout sporulation 
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(Losick & Stragier, 1992, Fimlaid et al., 2013, Saujet et al., 2013, Pereira et al., 2013). To 
further assess the sporulation phenotype of the CD3668 mutant, we performed fluorescence 
microscopy using the membrane specific dyes, FM4-64 and Mitotracker green (MTG). This 
technique allows the detection of earlier sporulation events, such as asymmetric septum 
formation (stage II) and engulfment of the prespore (stage III), neither of which is visible by 
phase contrast microscopy. At H24, there was a significant decrease in cells at stage II or 
beyond in the CD3668 mutant (6.1 ± 1.7%) compared to the parent strain (35.2 ± 3.9%; Fig. 
2C), indicating that fewer cells are able to achieve mature spore formation in the CD3668 
mutant compared to the parent strain. As there is no increase in sporulation frequency in the 
CD3668 mutant at H96 compared to H24 (Fig. S2), it is likely that sporulation in the CD3668 
mutant is arrested early.
Sporulation-specific gene expression is decreased in the CD3668 mutant
The decreases in sporulation frequency and in the formation of asymmetric sporulation septa 
in the CD3668 mutant suggest that sporulation-specific gene expression is reduced and/or 
delayed in this strain. To further characterize the sporulation phenotype of the CD3668 
mutant, we used qRT-PCR to measure the transcript levels of spo0A and the sporulation-
specific sigma factors at multiple time points during growth on 70:30 sporulation agar. 
Transcription of spo0A, which encodes the master regulator of sporulation, was unchanged 
between the parent strain and the CD3668 mutant (Fig. 3A). However, spo0A transcript 
levels do not fully correlate to Spo0A~P activity (Edwards et al., 2014), as is frequently 
observed with regulatory proteins. To evaluate Spo0A~P activity, we also analyzed 
transcription of sigE, an early stage sporulation-specific sigma factor that depends upon 
active Spo0A~P for its expression. We found that sigE expression appeared decreased at H8 
and H10 and was significantly decreased at H12 in the CD3668 mutant (~6-fold; Fig. 3B). 
Transcript levels of additional sporulation-specific sigma factors, sigF and sigG, trended 
lower at H8 and H10 and were significantly decreased at H12 in the CD3668 mutant (~2-fold 
and ~7-fold, respectively; Fig. 3C–D). Further, expression of another Spo0A-dependent 
gene, spoIIE, which encodes a phosphatase necessary for SigF activation, was also 
significantly decreased in the CD3668 mutant (Fig. S3A). These data indicate that 
sporulation-specific genes are expressed at lower levels in the CD3668 mutant, which 
correlates with the reduced sporulation phenotype observed.
As Spo0A activity is controlled by phosphorylation, we analyzed the expression of the three 
putative Spo0A sensor histidine kinases in C. difficile (Underwood et al., 2009). Transcript 
levels of CD1492, CD1579 and CD2492 were all increased in the absence of CD3668 (Fig. 
S3B), which suggests that levels of phosphorylated Spo0A would be higher in the CD3668 
mutant, contradicting the pattern of sporulation-specific gene expression observed above. 
Because the function of these three putative Spo0A kinases are not elucidated, there are 
likely additional regulatory interactions unknown that control sporulation initiation. Finally, 
sigE transcript levels were similarly decreased (~4-fold) in the CD3668 mutant grown in TY 
medium compared to growth on 70:30 sporulation agar (Fig. S4A versus Fig. 4B), indicating 
that CD3668 controls sporulation in multiple growth conditions.
Edwards et al. Page 5
Mol Microbiol. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Toxin gene expression and toxin production are increased in the CD3668 mutant
Sporulation and the production of the two primary C. difficile toxins, toxin A (TcdA) and 
toxin B (TcdB), have been linked in multiple C. difficile strains (Deakin et al., 2012, Mackin 
et al., 2013, Pettit et al., 2014), although a definitive regulatory pathway has not been 
identified. To determine whether the loss of CD3668 affects toxin production, we first 
analyzed tcdA and tcdB gene expression using qRT-PCR. Transcript levels of tcdA and tcdB 
were elevated in the CD3668 mutant when grown on 70:30 sporulation agar (~4-fold and 
~3.5-fold, respectively; Fig. 4A) or in TY medium (~6-fold; Fig. S4A), suggesting that 
CD3668 negatively influences toxin gene expression. Both tcdA and tcdB gene expression 
were complemented to wild-type levels when CD3668 expression was induced in the 
CD3668 mutant (Fig. S5A, B). Additionally, CD3668 overexpression in the 630Δerm parent 
background resulted in a ~2-fold decrease in tcdA transcript levels (Fig. S5A), further 
confirming that CD3668 represses toxin gene expression. Western blot analysis of cultures 
grown in TY medium demonstrated that TcdA protein levels were increased ~2.1-fold in the 
CD3668 mutant compared to the 630Δerm parent (Fig. 4B). No change in TcdA protein 
levels was detected in the CD2123 mutant (Fig. 4B), analogous to the toxin expression 
profiles for this strain (Fig. 4A).
Regulation of C. difficile toxin production is complex and is influenced by multiple 
regulatory factors. Expression of tcdA and tcdB is directly activated by the toxin-specific 
sigma factor, TcdR (Mani & Dupuy, 2001), while the motility sigma factor, SigD, directs 
tcdR transcription (McKee et al., 2013, El Meouche et al., 2013; Fig. 4). In addition, toxin 
gene expression is directly repressed by the global regulators, CodY (Dineen et al., 2007) 
and CcpA (Antunes et al., 2011, Antunes et al., 2012), in response to nutrient availability 
(Karlsson et al., 2008). To elucidate whether CD3668 controls tcdA and tcdB transcription 
directly or through one of the known regulators, we assessed tcdR transcript levels in the 
CD3668 mutant. Transcription of tcdR was ~3-fold higher in the CD3668 mutant compared 
to the parent strain or the CD2123 mutant (Fig. 4A). Altogether, these data indicate that 
CD3668 negatively affects C. difficile toxin production, likely through the toxin-specific 
sigma factor, TcdR.
CD3668 controls motility and toxin production through regulation of sigD expression
SigD is the only known positive regulator of the toxin-specific sigma factor, tcdR (El 
Meouche et al., 2013, McKee et al., 2013). As such, we next investigated the effects of 
CD3668 disruption on sigD expression. The abundance of the sigD transcript was ~2.5-fold 
higher in the CD3668 mutant compared to the parent strain grown on 70:30 sporulation agar 
(Fig. 5A), while a ~2-fold increase in sigD transcript occurred when grown in TY medium 
(Fig. S4A). The CD2123 mutant exhibited no change in sigD transcript levels, while the 
sigD transcript was ~2-fold lower in the sigD mutant (Fig. 5A), as previously shown (El 
Meouche et al., 2013). However, SigD is subject to post-translational regulation (El 
Meouche et al., 2013); thus, transcript abundance of sigD is not fully indicative of its 
activity. To determine if SigD-dependent gene expression was also affected in the CD3668 
mutant, we analyzed transcript levels of fliC, a SigD-dependent flagellar gene. Expression of 
fliC was significantly higher in the CD3668 mutant on 70:30 sporulation agar (Fig. 5A) and 
in TY medium (Fig. S4A). Likewise, fliC expression was significantly reduced when 
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CD3668 expression was induced in the CD3668 mutant (Fig. S5C). Expression of additional 
SigD-regulated genes, such as the early stage flagellar genes, flgB, motA and fliQ, were also 
higher in the CD3668 mutant (Fig. S6A), demonstrating that SigD-dependent gene 
expression is globally affected by the loss of CD3668. Finally, to determine if the CD3668-
dependent regulation of sigD transcription influences motility of C. difficile, swimming 
motility assays were performed using soft agar plates. As shown in Fig. 5B, the CD3668 
mutant exhibited a ~10% increase in swimming motility at 120 h compared to the parent 
strain. As anticipated, the sigD mutant control was nonmotile.
Although the data indicate that CD3668 signals through sigD expression to regulate toxin 
production, we assessed whether CD3668 could also influence the other known regulators of 
toxin expression, CodY and CcpA. Transcription of ccpA was unaffected, and a small 
decrease in codY expression was observed in the CD3668 mutant, but no consistent change 
in expression was found for genes controlled by these regulators (Fig. S6B, data not shown). 
Together, these results demonstrate that CD3668 regulates toxin expression in a SigD-
dependent manner. Because of the phenotypes affected by CD3668, we propose this locus be 
renamed rstA (regulator of sporulation and toxin, A).
Expression of rstA may be controlled through autoregulation
RNPP proteins often control their own expression (Lereclus et al., 1996, Lazazzera et al., 
1999, Mashburn-Warren et al., 2010). We asked whether the rstA mutation affects rstA 
expression. rstA transcript levels slightly increased in the parent strain during growth on 
70:30 sporulation agar (at H8 and H12; Fig. 6A) and remained unchanged during growth in 
TY medium (Fig. S4B). Expression of rstA was increased ~4–6-fold in the rstA mutant 
compared to the parent strain at all time points when grown on 70:30 sporulation agar (Fig. 
6A) and in TY medium (~3–5-fold; Fig. S4B), which suggests that RstA negatively 
influences its own expression. To further assess whether RstA affects rstA transcription, we 
constructed a PrstA::phoZ reporter fusion containing 489 bp upstream of the annotated rstA 
start codon and measured alkaline phosphatase (AP) activity in 630Δerm and the rstA 
mutant. AP activity was increased ~1.7-fold in the rstA mutant compared to the parent strain 
(Fig. 6B), further verifying that rstA inhibits its own expression. Altogether, these data 
strongly suggest that rstA transcription is autoregulatory.
As RNPP proteins and their cognate quorum sensing peptide are often co-transcribed or 
located adjacent to one another (Rocha-Estrada et al., 2010, Cook & Federle, 2014), we 
looked for potential open reading frames that may encode a precursor to a quorum sensing 
peptide or a similar regulatory feature; however, no candidate, short open reading frame that 
possibly encodes a peptide is apparent near the rstA locus. It is possible, however, that the 
one or both of the hypothetical genes downstream of rstA, CD3666 and CD3665, encode an 
unknown class of quorum sensing peptides.
The rstA mutant exhibits increased virulence in the hamster model of C. difficile infection
The TcdA and TcdB toxins are critical virulence factors in animal models of C. difficile 
infection (Kuehne et al., 2010). Because RstA inhibits toxin gene expression, we next asked 
whether the rstA mutant is more virulent in a hamster model of C. difficile infection (Chang 
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et al., 1978, Douce & Goulding, 2010, Best et al., 2012). Female Syrian golden hamsters 
were infected with the 630Δerm parent strain or the rstA mutant. Animals were monitored 
for symptoms of C. difficile infection, as described in the Experimental Procedures. 
Hamsters infected with the rstA mutant succumbed to C. difficile infection more quickly 
than those infected with the 630Δerm parent strain (P < 0.01, log rank test; mean times to 
morbidity: 45.5 ± 3.5 h for 630Δerm and 34.1 ± 2.6 h for the rstA mutant; one animal 
infected with 630Δerm survived the duration of the ten day study; Fig. 7A). These results 
indicate that the rstA mutant is more virulent than the parental strain.
To quantify the burden of total C. difficile vegetative cells and spores in vivo, fecal samples 
were collected 24 h post-infection and cecal contents were acquired at the time of morbidity. 
While there was no statistically significant difference in the number of C. difficile colony 
forming units (CFU) in feces 24 h post infection (Fig. 7B), significantly fewer CFU (~2.5-
fold) were enumerated from cecal contents for hamsters infected with the rstA mutant 
compared to those infected with 630Δerm (Fig. 7C). It is important to note that no 
significant in vitro growth defect was observed in the rstA mutant when grown in BHIS, TY 
or 70:30 sporulation media (data not shown), which may suggest that the rstA mutant forms 
fewer spores in vivo.
To determine if toxin gene expression was greater in vivo, as it is in vitro, RNA was isolated 
from the cecal contents of infected hamsters post-mortem. Cecal contents from an 
uninfected animal were included as a control. Expression analyses revealed that both tcdA 
and tcdB transcript levels were higher (~2.5- and ~1.6-fold, respectively) in animals infected 
with the rstA mutant, compared to those infected with the parent strain (Fig. 7D). Because 
RstA appears to control toxin expression through SigD, we also measured in vivo sigD 
transcription. Transcript levels of sigD were significantly higher (~2.6-fold) in hamsters 
infected with the rstA mutant (Fig. 7D), suggesting that RstA also regulates toxin production 
and motility in a SigD-dependent manner in vivo. Finally, because animals infected with the 
rstA mutant carried fewer total C. difficile cells in vivo, at the time of death (Fig. 7C), we 
asked whether a reduced sporulation frequency in vivo contributed to this phenotype. sigE 
transcription was examined in cecal contents to determine if sporulation-specific gene 
expression was decreased in vivo, as observed in vitro. sigE transcription was detected in 
most hamsters infected with the 630Δerm strain (n = 10/11); however, sigE transcripts were 
only detectable in two of the nine hamsters tested that were infected with the rstA mutant, 
even though other transcripts were readily measurable. The inability to detect sigE transcript 
levels in most of the rstA-infected hamsters may correlate with the reduced number of total 
C. difficile cells recovered from cecal contents if the rstA mutant is oligosporogenous in 
vivo. The gene expression patterns observed in infected hamsters suggest that the same 
RstA-mediated regulation of sporulation and toxin production identified in vitro, are also 
relevant in vivo.
RstA demonstrates bifunctional control of sporulation and SigD-dependent activity
The presence of a putative HTH DNA-binding motif and protein-interacting TPR domains 
suggests that RstA may interact with peptides and also serve as a DNA-binding 
transcriptional regulator. To assess the importance of the DNA-binding domain in RstA 
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function, a truncated RstA lacking 37 amino acids within the HTH domain, was expressed in 
the rstA mutant and evaluated for effects on sporulation and SigD-dependent gene 
expression (MC738, Table 2; Cabrera et al., 2014). Expression of the rstAΔHTH allele 
substantially restored sporulation of an rstA mutant but did not significantly affect SigD 
repression, as evidenced by SigD-dependent gene expression (Table 2). These results 
demonstrate that the HTH DNA-binding domain is dispensable for RstA-dependent 
stimulation of sporulation but is important for repression of SigD. Conversely, the five 
predicted peptide-interacting TPR domains that comprise the majority of RstA are sufficient 
to partially restore the sporulation-promoting functions of the protein, but are not adequate 
for repression of sigD expression.
DISCUSSION
Although C. difficile efficiently forms spores, many conserved regulatory proteins that are 
required for initiating sporulation in other studied spore-formers are not encoded in the C. 
difficile genome, suggesting that C. difficile employs unique regulatory mechanisms to 
control the early stages of sporulation. C. difficile does encode two weak orthologs to the 
Rap family of proteins, which inhibit sporulation in Bacillus species by indirectly preventing 
the accumulation of phosphorylated Spo0A, the active form of the master regulator of 
sporulation. In contrast, our study demonstrates that one C. difficile Rap-like protein, RstA 
(CD3668), functions as a novel regulator to increase sporulation and decrease motility and 
toxin production (Fig. 8).
Our results reveal that RstA regulates several physiological processes and virulence in C. 
difficile in multiple in vitro conditions. RstA positively affects the initiation of sporulation 
through its peptide-interacting TPR domains. RstA likely influences early sporulation 
events, as the majority of rstA mutant cells do not advance beyond Stage II of sporulation 
and gene expression of Spo0A-dependent genes and early-sporulation sigma factors is 
decreased. In addition, RstA negatively influences TcdA and TcdB toxin production and 
motility by repressing transcription of sigD, resulting in higher expression of toxins in vivo 
and increased virulence when the rstA mutant is used in the hamster model of C. difficile 
infection. Our data demonstrate that RstA regulates toxin expression through SigD, the 
flagellar-specific sigma factor. Removal of the HTH DNA-binding motif and examination of 
sporulation in a sigD mutant revealed that RstA controls sporulation initiation through a 
SigD-independent pathway. Based on these results, we hypothesize that RstA may be a 
global regulator in C. difficile, similar to the broad physiological roles RNPP proteins play 
in other bacteria.
While RstA exhibits more amino acid similarity to the Bacillus Rap proteins, RstA shares 
more features in common with the other members of the RNPP family of proteins. The 
RNPP family of regulatory proteins controls diverse traits, including sporulation, 
competence, toxin production and conjugation, in response to the direct binding of small 
quorum peptides to the TPR domains (reviewed in: Rocha-Estrada et al., 2010, Cook & 
Federle, 2014). The RNPP proteins are characterized by the tetratricopeptide repeat (TPR) 
domains found in the C-terminal portion of these proteins. Multiple TPR domains of the 
RNPP proteins are arrayed in tandem, and form stacked alpha-helical surfaces that facilitate 
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the binding of small quorum sensing peptides (Declerck et al., 2007, Diaz et al., 2012). The 
N-terminal effector domains of RNPP proteins function as phosphatases and/or 
transcriptional regulators. Peptide binding to the protein induces a conformational change 
that either activates or inhibits the phosphatase activity or DNA-binding capabilities of an 
RNPP protein (Grenha et al., 2013, Parashar et al., 2013, Gallego del Sol & Marina, 2013, 
Zouhir et al., 2013).
RstA contains several TPR domains that share similarity with the Bacillus Rap proteins; 
however, the conserved N-terminal HTH DNA-binding motif and predicted protein structure 
are more similar to the other RNPP members, namely B. thuringiensis PlcR and the B. 
cereus group NprR (Fig. 1). The secondary structure of PlcR, which is a DNA-binding 
transcriptional activator when bound to its cognate peptide (Slamti & Lereclus, 2002), aligns 
with residues 5–190 and 350–428 of RstA, which leaves an approximate 160 residues 
between the putative HTH DNA-binding motif and the C-terminal TPR domains (Fig. 1). 
RstA also aligns with much of the full-length bifunctional RNPP regulatory protein, NprR 
(Fig. 1). NprR is the only known RNPP protein that both directly binds DNA to regulate 
gene transcription and directly interacts with the phosphotransfer protein, Spo0F (Cabrera et 
al., 2014). NprR contains a conserved HTH DNA-binding domain followed by a region that 
is similar to the Rap proteins and contains several conserved residues that mediate Spo0F 
binding (Cabrera et al., 2014). The Spo0F-binding domain of NprR is composed of two TPR 
domains (Zouhir et al., 2013) and is similar to the secondary structure predicted for RstA in 
this region (Fig. 1). Our data and the structural similarity between RstA and the other RNPP 
proteins suggest that RstA functions as a DNA-binding regulator and possesses a protein-
binding domain.
Multiple attempts to demonstrate direct RstA binding to potential DNA targets, including a 
putative sigD promoter (PflgB) and the rstA promoter, through in vitro electrophoretic 
mobility shift assays were unsuccessful. The absence of RstA-DNA binding in vitro may be 
attributable to several factors: 1) RstA requires a cofactor, such as a small quorum sensing 
peptide, to bind DNA, as is the case for other RNPP proteins (Slamti & Lereclus, 2002, 
Perchat et al., 2011); 2) the DNA fragments tested are not direct RstA targets or 3) RstA is 
not a DNA-binding protein. To test if RstA requires an additional cofactor to bind DNA with 
high affinity, concentrated supernatants from C. difficile 630Δerm parent, the opp app 
mutant (Edwards et al., 2014) or the rstA mutant strains grown on 70:30 sporulation agar 
were added to the binding reactions, but no binding was observed. It remains unclear 
whether C. difficile employs quorum sensing to regulate sporulation initiation. To our 
knowledge, there is no published evidence of quorum sensing regulation in C. difficile 
sporulation, and our previous study revealed that the Opp and App oligopeptide permeases 
negatively influence sporulation, likely through nutrient acquisition rather than quorum 
sensing (Edwards et al., 2014). In addition, a recent study revealed that the absence of 
multiple Rap proteins in gastrointestinal isolates of B. subtilis leads to earlier Spo0A 
activation and cell density-independent sporulation (Serra et al., 2014). C. difficile may also 
utilize similar regulatory mechanisms. However, it is also possible that the nutrient 
starvation occurring in the opp app mutant masks the loss of the potential RstA-dependent 
quorum sensing, resulting in the increased sporulation phenotype observed. It is important to 
note that the Agr quorum sensing system positively controls sporulation in other related non-
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pathogenic and pathogenic clostridial organisms, including C. acetobutylicum, C. botulinum 
and C. perfringens (Cooksley et al., 2010, Li et al., 2011, Steiner et al., 2012); however, the 
regulatory pathways have not been elucidated. The C. difficile genome contains one to two 
encoded agr systems (Darkoh et al., 2015). The partial Agr1 system in C. difficile 630 has 
not been studied to our knowledge, and thus, its influence on sporulation is unknown. 
Finally, there remains the possibility that a host-derived signal triggers sporulation in an 
RstA-dependent manner.
Determining the genetic interactions through which RstA induces spore formation in C. 
difficile is a focus of future studies, as is determining how rstA expression and activity is 
controlled. Transcription of rstA in 630Δerm varies less than 2-fold throughout sporulation, 
and overexpression of rstA in the parent background does not increase sporulation, 
suggesting that regulation of RstA activity is controlled post-transcriptionally. Although 
regulation of sigD transcription by RstA requires the putative DNA-binding region, this 
activity also likely involves specific peptide interactions mediated by the TPR repeat 
domains. As evidenced by the restoration of sporulation with a truncated RstAΔHTH allele 
expressed in the rstA background, RstA functions as a transcriptional regulator and has 
additional regulatory functions that likely require protein interaction. As a bifunctional 
protein, the regulatory activity of RstA is expected to be complex, as is the case for the 
related RNPP protein, NprR (Cabrera et al., 2014).
RstA is highly conserved in all sequenced C. difficile genomes, suggesting that its function 
is conserved as well. RstA orthologs are also encoded in pathogenic and non-pathogenic 
Clostridium and closely related organisms, including C. botulinum, C. perfringens, C. 
sordellii, C. acetobutylicum and C. butyricum, which suggests an important role for RstA in 
clostridial physiology and pathogenesis. Although the regulation and function of the C. 
difficile sporulation-specific sigma factors and additional sporulation regulators differ from 
other clostridia (Fimlaid et al., 2013), RstA may similarly regulate early sporulation events 
in both C. difficile and other clostridial organisms. These findings underscore the unique 
molecular mechanisms that C. difficile, and likely clostridia, use to promote virulence, 
sporulation, motility and toxin production, and have revealed an important regulatory protein 
that regulates these physiological processes during C. difficile infection.
EXPERIMENTAL PROCEDURES
Bacterial strains and growth conditions
The bacterial strains and plasmids used in this study are listed in Table 3. Clostridium 
difficile strains were routinely cultured in BHIS or TY broth or on BHIS agar plates and 
supplemented with 2–10 μg ml−1 thiamphenicol, 5 μg ml−1 erythromycin or 0.5–1 μg ml−1 
nisin (Sigma-Aldrich) as needed (Smith et al., 1981). Counterselection of E. coli after 
conjugation with C. difficile was performed using 50 μg ml−1 kanamycin as previously 
described (Purcell et al., 2012). Taurocholate (0.1%, Sigma-Aldrich) and fructose (0.2%) 
were added to C. difficile cultures to induce germination of C. difficile spores and prevent 
sporulation, respectively, as indicated (Sorg & Dineen, 2009, Putnam et al., 2013). C. 
difficile strains were cultured in an anaerobic chamber maintained at 37°C (Coy Laboratory 
Products) with an atmosphere of 10% H2, 5% CO2 and 85% N2 as previously described 
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(Edwards et al., 2013). Escherichia coli strains were grown at 37°C in LB (Luria & Burrous, 
1957) or BHIS medium, unless otherwise stated, and supplemented with 20 μg ml−1 
chloramphenicol and/or 100 μg ml−1 ampicillin as needed.
Strain and plasmid construction
Oligonucleotides used in this study are listed in Fig. S7. Details of DNA cloning and vector 
construction are outlined in Fig. S8. C. difficile strain 630 (Genbank no. NC_009089.1) was 
used as a template for primer design and C. difficile strain 630Δerm was used for PCR 
amplification, unless otherwise specified. Isolation of plasmid DNA, PCR and cloning were 
performed using standard protocols. Additional genetic manipulations of C. difficile were 
performed as previously described (Bouillaut et al., 2011). Null mutations in C. difficile 
were created by retargeting the group II intron from pCE240 using the intron retargeting 
primers listed in Fig. S7, as previously described (Karberg et al., 2001, Ho & Ellermeier, 
2011, Heap et al., 2007). To complement the CD3668 disruption, a control plasmid 
(pMC211; Edwards et al., 2014) or plasmids containing the CD3668 wild-type, histidine-
tagged or HTH motif deletion gene driven by the cprA promoter (pMC367, pMC519 and 
pMC520; McBride & Sonenshein, 2011b, Purcell et al., 2012, Suarez et al., 2013) was 
transferred into C. difficile strains from E. coli by conjugation as previously described, 
except that 50 μg ml−1 kanamycin was used to counterselect against E. coli post-conjugation 
(McBride & Sonenshein, 2011a). Cloned DNA fragments were verified by sequencing 
(Eurofins MWG Operon).
Southern blot analysis
Genomic DNA from 630Δerm, MC379, MC391 and RT1075 was isolated following a 
modified Bust n’ Grab protocol (Harju et al., 2004). Briefly, 6 ml of C. difficile culture was 
washed with TE Buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0) before the cells 
were suspended in 400 μl lysis buffer (2% Triton X-100, 1% SDS, 100 mM NaCl, 10 mM 
Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0). Cells were lysed as described except samples were 
exposed to a dry ice-ethanol bath for 2 min and boiled for 2 min twice. Lysed cells were 
removed by phenol:chloroform:isoamyl alcohol (25:24:1) extraction and subsequent 
chloroform extraction. Contaminating RNA was removed by incubation with RNase A 
(Ambion) for 30 min at 37°C. Genomic DNA was digested, separated and transferred and 
fixed onto Hybond-N+ nylon membranes (GE Healthcare) as previously described (Edwards 
et al., 2014). Southern blot analysis was performed using a DIG High Prime labeling and 
detection kit (Roche) and an intron-specific probe (Saujet et al., 2013).
Sporulation assays and phase contrast microscopy
C. difficile cultures were started in BHIS medium supplemented with 0.1% taurocholate and 
0.2% fructose, to induce germination of C. difficile spores and prevent sporulation, 
respectively, until late-log phase. Cultures were then diluted in BHIS to an optical density at 
600 nm (OD600) of 0.5. These cultures (250 μl) were applied to 70:30 sporulation agar as a 
lawn (Putnam et al., 2013). Plates were incubated at 37°C and monitored for the production 
of spores. At the indicated time points, cells were scraped from the plates, suspended in 
BHIS medium and removed from the chamber. Sample and slide preparation was performed 
as previously described (Edwards et al., 2014). Phase contrast microscopy was performed 
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using a X100 Ph3 oil immersion objective on a Nikon Eclipse Ci-L microscope. At least two 
fields of view for each strain were acquired with a DS-Fi2 camera, and at least 1000 cells 
per independent experiment were enumerated to calculate the percentage of spores (the 
number of spores divided by the total number of spores and vegetative cells) from at least 
three independent experiments.
Ethanol resistance assays
C. difficile strains were grown on 70:30 sporulation agar as described above, and ethanol 
resistance assays were performed as previously described (Edwards et al., 2014). Briefly, 
after 24 h growth (H24), cells were scraped from the plates and suspended in 70:30 
sporulation liquid medium to an OD600 = 1.0. Cells were immediately serially diluted in 
70:30 sporulation liquid medium and plated onto BHIS + 0.1% taurocholate plates to 
enumerate all viable vegetative cells and spores. An 0.5 ml aliquot of culture was removed 
from the chamber, mixed with 0.5 ml 95% ethanol, vortexed and incubated at room 
temperature for 15 min. Ethanol-treated cells were serially diluted in 1X PBS, brought back 
into the chamber and plated onto BHIS + 0.1% taurocholate plates to enumerate spores. 
After 24 h of growth, CFU were enumerated, and the sporulation frequency was calculated 
as the number of ethanol resistant spores divided by the total number of viable cells. A 
spo0A mutant (MC310) was used as a negative control.
Fluorescence Microscopy
C. difficile strains were grown on 70:30 sporulation agar as described above. After 24 h 
growth (H24), cells were scraped from the plates, suspended in 0.5 ml BHIS and pelleted at 
room temperature. The supernatant was removed, cells were suspended in 50 μl BHIS, and 
the membrane specific dyes FM4-64 and MitoTracker Green (Life Technologies) were 
added to the samples at a final concentration of 165 μM and 100 μM, respectively. Cells 
were incubated for 20 min in the dark at room temperature, and slides were prepared as 
previously described (Edwards et al., 2014), using a 24x55 mm #1 coverslip. Fluorescence 
microscopy was performed using a X100 oil immersion objective (numerical aperture, 1.49) 
on a Nikon structured illumination microscope (N-SIM). At least three fields of view for 
each strain were used to calculate the percentage of cells entering sporulation from at least 
three independent biological replicates. The percentage of sporulating cells was defined as 
the number of cells possessing polar septa, partially/completely engulfed forespores or fully 
formed spores (stage II and beyond) divided by the total number of cells.
RNA isolation and quantitative reverse transcription PCR analysis (qRT-PCR)
Samples of C. difficile were grown on 70:30 sporulation agar as described above, and cells 
were harvested from plates directly into 1.5:1.5:3 ethanol:acetone:dH2O. RNA was purified 
as previously described (Dineen et al., 2010, McBride & Sonenshein, 2011b, Edwards et al., 
2014), and cDNA synthesis was performed as previously detailed (Edwards et al., 2014). 
Either 50 ng (samples isolated from in vitro cultures) or 200 ng (samples isolated from 
hamster cecal content) cDNA per reaction mixture was used for quantitative reverse-
transcription PCR (qRT-PCR) analysis. qRT-PCR analysis was performed using SensiFAST 
SYBR & Fluorescein kit (Bioline) and a Roche Lightcycler 96. Control cDNA synthesis 
reactions containing no reverse transcriptase were included to identify genomic 
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contamination. Primers for qRT-PCR analysis were designed using PrimerQuest (Integrated 
DNA Technologies), and primer efficiencies were calculated for each primer set prior to use. 
qRT-PCR was performed in technical triplicate for each cDNA sample and primer pair and 
on cDNA isolated from a minimum of three biological replicates. Results were calculated by 
the comparative cycle threshold method (Schmittgen & Livak, 2008) and normalized to the 
rpoC transcript. Results are presented as the means and standard errors of the means, and a 
two-tailed Student’s t test was performed to determine statistical significance.
Motility Assays
C. difficile strains were grown overnight in BHIS medium supplemented with 0.1% 
taurocholate and 0.2% fructose as detailed above. Cultures were diluted to an OD600 of 0.5 
in BHIS broth, and 5 μl of culture was stabbed in the center of one-half concentration BHI 
plates with 0.3% agar. The diameter of cell growth was measured every 24 h for five days, 
and the results represent four independent experiments. Results are presented as means and 
standard errors of the means, and a two-tailed Student’s t test was performed for statistical 
comparison of mutant outcomes to the parent strain.
Alkaline Phosphatase (AP) Assays
AP assays were performed as previously described (Edwards et al., 2015) with the following 
modifications. Briefly, C. difficile strains were grown on 70:30 sporulation agar as described 
above, and cells were harvested from plates at H8 and suspended directly into 1 ml dH2O to 
an OD600 of 0.5. Cells were pelleted and stored overnight at −20°C, and the AP assay was 
continued as previously described, except that no chloroform was used for cell lysis 
(Edwards et al., 2015). Technical duplicates for each sample were performed and averaged, 
and results are presented as means and standard error of the means of four biological 
replicates. The two-tailed Student’s t test was used to compare the results of the mutant to 
the parent strain.
Animal Studies
Female Syrian golden hamsters (Mesocricetus auratus) weighing between 75–100 g were 
obtained from Charles River Laboratories and housed individually in sterile cages in an 
animal biosafety level 2 facility in the Emory University Division of Animal Resources. 
Hamsters were fed a standard rodent diet and offered water ad libitum. Seven days prior to 
inoculation with C. difficile, the hamsters were administered one dose of clindamycin (30 
mg kg−1 of body weight) by oral gavage to enable susceptibility to C. difficile infection. 
Hamsters were inoculated with approximately 5000 spores of a single strain of C. difficile 
(630Δerm or MC391) seven days after antibiotic administration. Negative control animals 
were administered clindamycin to induce susceptibility to disease but were not infected with 
C. difficile. Hamsters were weighed at least daily and monitored for signs of disease (weight 
loss, lethargy, diarrhea and wet tail), and fecal samples were collected daily for enumeration 
of total C. difficile CFU. Hamsters were considered moribund if they lost 15% or more of 
their highest weight or if they presented with disease symptoms of lethargy, diarrhea and wet 
tail. To prevent suffering, animals meeting either criterion were euthanized by CO2 
asphyxiation and subsequent thoracotomy. At the time of death, animals were necropsied, 
and cecal contents were obtained for enumeration of total C. difficile CFU as well as stored 
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in 1:1 ethanol-acetone solution at −80°C for RNA isolation and subsequent qRT-PCR 
analysis. Two independent experiments were performed in cohorts of six animals per C. 
difficile strain. For enumeration of C. difficile CFU, fecal samples were weighed, and fecal 
and cecal samples were suspended in 1X PBS, heated to 55°C for 20 min to eliminate 
significant background growth of other organisms, and plated onto the C. difficile selective 
agar, taurocholate cycloserine cefoxitin fructose agar (TCCFA; George et al., 1979, Wilson 
et al., 1982). C. difficile colony forming units, which derived from vegetative cells and 
germinated spores, were enumerated after 48 h. This standard preparation of fecal samples 
does not significantly reduce vegetative cells numbers, and this method does not distinguish 
vegetative cells from spores (data not shown). Therefore, our results represent total C. 
difficile cells recovered from fecal and cecal contents. Differences in C. difficile CFU 
recovered from fecal and cecal content samples were determined by a two-tailed Student’s t 
test (Excel; Microsoft), and differences in hamster survival between those infected with C. 
difficile 630Δerm or MC391 were analyzed using the log rank test (GraphPad Prism 6).
Western blot analysis
Strains were grown in TY medium overnight and then diluted into fresh TY medium. After 
incubation for 24 h at 37°C, bacterial cells were collected by centrifugation and suspended 
in SDS-PAGE loading buffer (62.5 mM Tris-HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% 
Bromophenol Blue, 5% 2-mercaptoethanol). The samples were separated by electrophoresis 
on pre-cast TGX 4–15% gradient gels (BioRad), and then transferred to nitrocellulose 
membranes. TcdA was detected using mouse anti-TcdA antibodies (Novus Biologicals). 
RNA polymerase β-subunit served as a loading control and was detected using mouse anti-
RNAP antibodies (Abcam). Goat anti-mouse IgG conjugated with IR800 dye was used as 
the secondary antibody. The blots were imaged and densitometry analyses were performed 
using an Odyssey imaging system (LI-COR). The intensities of the bands corresponding to 
TcdA were normalized to those of the RNAP band. To calculate fold changes, TcdA protein 
levels of each mutant were normalized to 630Δerm TcdA protein levels. The data presented 
are the mean values and standard error of the mean of the fold changes relative to the parent 
strain.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Identification of putative Rap orthologs in C. difficile
Comparison of C. difficile 630 (Genbank no. AM180355) CD2123 and CD3668 to the 
RapA and RapB proteins of B. subtilis 168 (AL009126), and of CD3668 to the PlcR 
(AVF21202.1) and NprR (ABK83928) proteins of B. thuringiensis. Similarity to 
tetratricopeptide repeat (TPR) domains were determined through BLAST and TPRpred 
(Karpenahalli et al., 2007) analyses. TPR domain similarity is represented by outlines in 
pink (B.s. RapA), purple (B.s. RapB) and orange (B.s. RapE), while the TPR motifs outlined 
in green correlate to those found in B. thuringiensis. The Spo0F-binding domain of B. 
thuringiensis NprR is composed of TPR domains 1 and 2. Additional conserved protein 
domains are included.
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Figure 2. Sporulation is unaffected in a CD2123 mutant and significantly decreased in a CD3668 
mutant
(A) Representative phase contrast micrographs of 630Δerm and the CD2123 (MC379), 
CD3668 (MC391) and sigD (RT1075) mutants grown on 70:30 sporulation agar at H24. 
Open arrowheads indicate phase bright spores. Scale bars represent 10 μm. (B) Sporulation 
frequency of 630Δerm pMC211 (MC282, vector control), 630Δerm pPcprA::CD3668 
(MC478), CD3668 pMC211 (MC505, vector control) and CD3668 pPcprA-CD3668 
(MC480) grown on 70:30 sporulation agar supplemented with 2 μg ml−1 thiamphenicol and 
in the absence or presence of 0.5 μg ml−1 and 1 μg ml−1 nisin. Sporulation frequency is 
calculated from phase contrast micrographs obtained at H24. ND = not determined. (C) 
Fluorescence microscopy of 630Δerm and the CD3668 mutant using the membrane-specific 
dyes FM4-64 and Mitotracker Green (MTG). Open arrowheads point to partially or 
completely engulfed prespores and spores, while hatched arrowheads indicate polar septa. 
For phase contrast and fluorescence microscopy, samples were removed at the indicated 
times and prepared for microscopy as described in the Experimental Procedures. The 
percentage of total cells at Stage II+ are shown. The means and standard error of the means 
of at least four biological replicates are shown (*, P ≤ 0.05 by a two-tailed Student’s t test).
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Figure 3. Sporulation-specific gene expression is decreased in a CD3668 mutant
qRT-PCR analysis of (A) spo0A and the sporulation-specific sigma factors, (B) sigE, (C) 
sigF and (D) sigG expression in 630Δerm and CD3668 (MC391) grown on 70:30 
sporulation agar at H6, H8, H10 and H12. The means and standard error of the means of four 
biological replicates are shown (*, P ≤ 0.05 by a two-tailed Student’s t test).
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Figure 4. Toxin gene expression and TcdA protein levels are increased in a CD3668 mutant
(A) qRT-PCR analysis of tcdA, tcdB and tcdR in 630Δerm, sigD (RT1075), CD2123 
(MC379) and CD3668 (MC391) grown on 70:30 sporulation agar at H12. The means and 
standard error of the means of four biological replicates are shown (*, P ≤ 0.05 by a two-
tailed Student’s t test). (B) Western blot analysis of TcdA and RNAP (RpoB′) in 630Δerm, 
tcdR (RT854), sigD (RT1075), CD3668 (MC391) and CD2123 (MC379) grown in TY 
medium at 24 h. The means and standard error of the means of three biological replicates are 
shown, and bold text indicates P ≤ 0.05 by a two-tailed Student’s t test.
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Figure 5. CD3668 represses sigD gene expression and motility
(A) qRT-PCR analysis of sigD and fliC in 630Δerm, sigD (RT1075), CD2123 (MC379) and 
CD3668 (MC391) grown on 70:30 sporulation agar at H12. The means and standard error of 
the means of four biological replicates are shown (*, P ≤ 0.05 by a two-tailed Student’s t 
test). (B) Swimming of 630Δerm, sigD (RT1075) and CD3668 (MC391) in one-half 
concentration BHI with 0.3% agar. The swim diameters (mm) were measured every 24 h for 
a total of 120 h. The means and standard error of the means of four biological replicates are 
shown (*, P ≤ 0.05 by a two-tailed Student’s t test). Where error bars are not visible, they are 
obscured by the symbols.
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Figure 6. Expression of rstA is increased in the rstA mutant
(A) qRT-PCR analysis of CD3668 in 630Δerm and CD3668 (MC391) grown on 70:30 
sporulation agar at H6, H8, H10 and H12. (B) Alkaline phosphatase (AP) activity of the 
PrstA::phoZ reporter fusion in 630Δerm and CD3668 (MC391) grown on 70:30 sporulation 
agar at H8. The means and standard error of the means of four biological replicates are 
shown (*, P ≤ 0.05 by a two-tailed Student’s t test).
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Figure 7. Disruption of CD3668 results in increased morbidity in the hamster model of C. difficile 
infection
(A) Kaplan-Meier survival curve representing the cumulative results from two independent 
experiments of clindamycin-treated Syrian golden hamsters inoculated with 5000 spores of 
C. difficile 630Δerm (n = 12) or MC391 (CD3668; n = 12). Mean times to morbidity were: 
630Δerm, 45.5 ± 3.5 h (n = 11); CD3668 (MC391), 34.1 ± 2.6 h (n = 12); P < 0.01, log rank 
test. Total number of C. difficile colony forming units (CFU) per (B) gram of feces 
recovered at 24 h post infection or (C) ml of cecal content recovered at time of morbidity 
from the same two independent experiments described in the legend for panel A (*, P ≤ 0.05 
by a two-tailed Student’s t test). Solid lines represent the median for each strain; dotted line 
denotes the limit of detection (2 x 101 CFU/g or CFU/ml). (D) qRT-PCR analysis of tcdA, 
tcdB, sigD and sigE transcript levels in cecal contents of hamsters infected with 630Δerm (n 
= 9 for tcdA and sigE analyses; n = 10 for tcdB and sigD analyses) or MC391 (CD3668; n = 
9 for tcdA analysis; n = 8 for tcdB and sigD analyses). The means and standard error of the 
means are shown (*, P ≤ 0.05 by a two-tailed Student’s t test; ND, not detected)
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Figure 8. 
Model of C. difficile toxin and sporulation regulation. RstA negatively impacts its own 
expression. RstA positively affects sporulation through an undetermined regulatory pathway. 
RstA negatively influences both motility and toxin production through the flagellar-specific 
sigma factor, SigD. In addition, CodY directly represses tcdR transcription (Dineen et al., 
2007), and CcpA directly represses tcdR, tcdA and tcdB gene expression (Antunes et al., 
2011, Antunes et al., 2012). However, CodY- and CcpA-dependent toxin regulation is not 
influenced by RstA in the conditions tested.
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Table 3
Bacterial strains and plasmids
Plasmid or Strain Relevant genotype or features Source, construction or reference
Strains
E. coli
 DH5αMax F− ϕ80lacZΔM15 Δ(lacZYA-argF) Invitrogen
 Efficiency U169 recA1 endA1 hsdR17 (rk−, mk+) phoA supE44 λ−thi−1 gyrA96 relA1
 MC101 HB101 pRK24 B. Dupuy
 MC277 HB101 containing pRK24 and pMC211 (Edwards et al., 2014)
 MC369 HB101 containing pRK24 and pMC303 This study
 MC385 HB101 containing pRK24 and pMC325 This study
 MC460 HB101 containing pRK24 and pMC367 This study
 MC734 HB101 containing pRK24 and pMC519 This study
 MC735 HB101 containing pRK24 and pMC520 This study
 MC772 HB101 containing pRK24 and pMC543 This study
C. difficile
 630 Clinical isolate (Wust & Hardegger, 1983)
 630Δerm ErmS derivative of strain 630 N. Minton and (Hussain et al., 2005)
 MC282 630Δerm pMC211 (Edwards et al., 2014)
 MC310 630Δerm spo0A::erm (Edwards et al., 2014)
 MC379 630Δerm CD2123::erm This study
 MC391 630Δerm rstA::erm This study
 MC478 630Δerm pMC367 This study
 MC480 630Δerm rstA::erm pMC367 This study
 MC505 630Δerm rstA::erm pMC211 This study
 MC737 630Δerm rstA::erm pMC519 This study
 MC738 630Δerm rstA::erm pMC520 This study
 MC773 630Δerm pMC543 (PrstA::phoZ) This study
 MC774 630Δerm rstA::erm pMC543 (PrstA::phoZ) This study
 RT854 630Δerm tcdR::erm (McKee et al., 2013)
 RT1075 630Δerm sigD::erm (Bordeleau et al., 2015)
Plasmids
 pRK24 Tra+, Mob+; bla, tet (Thomas & Smith, 1987)
 pCR2.1 bla, kan Invitrogen
 pCE240 C. difficile TargeTron® construct based on pJIR750ai (group II intron, 
ermB::RAM, ltrA); catP
C. Ellermeier
 pSMB47 Tn916 integrational vector; CmR, ErmR (Manganelli et al., 1998)
 pMC123 E. coli-C. difficile shuttle vector; bla, catP (McBride & Sonenshein, 2011b)
 pMC211 pMC123 with cprA promoter, bla catP (Edwards et al., 2014)
 pMC289 pCR2.1 with group II intron targeted to CD2123 This study
 pMC292 pCE240 with CD2123-targeted intron This study
 pMC303 pMC123 with CD2123-targeted intron, ermB::RAM, ltrA; catP This study
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Plasmid or Strain Relevant genotype or features Source, construction or reference
 pMC320 pCR2.1 with group II intron targeted to CD3668 (rsdA) This study
 pMC323 pCE240 with CD3668-targeted intron This study
 pMC325 pMC123 with CD3668-targeted intron, ermB::RAM, ltrA; catP This study
 pMC358 pMC123 phoZ (Edwards et al., 2015)
 pMC367 pMC211 CD3668 This study
 pMC519 pMC211 CD3668-HIS6x This study
 pMC520 pMC211 CD3668ΔHTH- HIS6x This study
 pMC543 pMC358 PrstA::phoZ This study
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